| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.37 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |